Разработка комплексного лечения пациентов с хроническим аутоиммунным тиреоидитом с применением компьютерной рефлексотерапии проводимой на фоне заместительной гормональной терапии

166. Luidens M.K., Mousa S.A., Davis F.B., Thyroid hormone and angiogenesis. Vasc Pharmacol. 2010; 52: 142-145. doi: 10.1016/ j.vph.2009.10.007.

167. Lund I., Lundeberg T. Are minimal, superficial or sham acupuncture procedures acceptable as inert placebo controls? / I. Lund, // Acupunct. Med. - 2006. - Vol. 24(1). - P. 13-15.

168. Mistry N., Wass J., Turner M.R. When to consider thyroid dysfunction in the neurology clinic // Pract. Neurol. 2009. Vol. 9, N 3. P.145-156.

169. Mndez I., Cario C., Daz L. Prolactin in the immunological system: synthesis and biological effects // Rev. Invest. Clin. 2005. Vol. 57,N 3. P. 447-456.

170. Nakatani Y., Yamashita K. "Ryodoraku acupuncture", Tokyo, Japan, 1977.

171. Nazarpour S., Tehrani F. R., Simbar M. Comparison of universal screening with targeted high-risk case finding for diagnosis of thyroid disorders. //. Eur J Endocrinol. - 2016. - Vol. 174. - P. 77-83.

172. Nygaard B., Jensen E.W., Kvetny J. Effect of combination therapy with thyroxine (t4) and 3,5,3''-triiodothyronine versus t4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study. // Eur J Endocrinol. 2009;161(6):895-902.

173. Okamoto Y. Hashimoto's thyroiditis. //. Nippon Rinsho. 2006. Vol.28, Suppl. 1. P. 434-437.

174. Ott J., Meusel M., Schultheis A. The incidence of lymphocytic thyroid infiltration and Hashimoto's thyroiditis increased in patients operated for benign goiter over a 31-year period . //. Virchows Arch. - 2011. - №3. - P. 277-281.

175. Panicker V., Evans J., Bjoro T. A paradoxical difference in relationship between anxiety, depression and thyroid function in subjects on and not on t4: Findings from the hunt study. // Clin Endocrinol (Oxf). 2009;71(4):574-580.

176. Pandi-Perumal S.R., Srinivasan V., Maestroni G.J., Cardinali D.P., Poeggeler B. Melatonin: Nature's most versatile biological signal? 2006. FEBS J 273: 2813-2838.

177. Purnaiah M., Rakesh G. Clinical study of Hasihmoto's thyroiditis & its management. J. Evid. Based Med. Healthc. 2016; 3(21), 931-935. DOI: 10.18410/jebmh/2016/211

178. Patel H., Mansuri M. S., Singh M. Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism. //. PLoS One. - 2016. - Vol. 10. - № 3. - e0149441.

179. Pearce E.N., Yang Q., Benjamin E.J. Thyroid function and left ventricular structure and function in the Framingham Heart Study. // Thyroid. 2010;20(4):369-373.

180. Pearce S.H.S., Brabant G., Duntas L.H., 2013 eta guideline: Management of subclinical hypothyroidism. // Eur Thyroid J. 2013;2(4):215-228.

181. Pіoski R., Szymaсski K., Bednarczuk T. The Genetic Basis of Grave's Disease.CurrentGenomics 2011,12 IF: 2.487.

182. Prummel M. F., Strieder T. G., Wiersinga W. M. The environment and autoimmune thyroid diseases. //. European Journal of Endocrinology. - 2004. - Vol. 150. - P. 605-618.

183. Pyzik Aleksandra, Grywalska Ewelina, Matyjaszek-Matuszek Beata, RoliNski Jacek. Immune Disorders in Hashimoto's Thyroiditis: What Do We Know So Far? Hindawi Publishing Corporation Journal of Immu-nology Research Volume 2015, Article ID 979167, 8 pages.

184. Rodondi N., Bauer D.C., Cappola A.R. Subclinical Thyroid Dysfunction, Cardiac Function, and the Risk of Heart Failure.The Cardiovascular Health Study // J. Am. Col. Cardiology. 2008.V. 14. P. 1152§1159.

185. Rodondi N., Den Elzen W.P.J., Bauer D.C. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. // JAMA. 2010; 304(12):1365.

186. Russell W., Harrison R.F., Smith N. et al. Free triiodothyronine has a distinct circadian rhythm that is delayed but parallels thyrotropin levels // J. Clin. Endocrin. Metab. 2008. V. 93(6). P. 2300-2306.

187. Saranac L., Zivanovic S., Bjelakovic S. Why Is the Thyroid So Prone to Autoimmune Disease?//. Horm Res Paediatr. - 2011. - Vol. 75. - P. 157-165.

188. Schultheiss U. T., Teumer A. A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations / 102 M. Medici. //. J Clin Endocrinol Metab. - 2015. - Vol. 100. - P. 799-807.

189. Shah M. S., Davies T. F., Stagnaro-Green A. The thyroid during pregnancy: a physiological and pathological stress test.//. Minerva Endocrinol. 2003. Vol. 28 (3). P. 233 - 245.

190. Singh S., Duggal J., Molnar J. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all§cause mortality: a meta§analysis // Intern. J. Cardiol. 2008. V. 125.P. 41-48.

191. Sisto M., Cucci L., D'Amore M. Proposing a relationship between Mycobacterium avium subspecies paratuberculosis infection and Hashimoto's thyroiditis. //Scandinavian Journal of Infectious Diseases. - 2010. - Vol. 42, № 10. - P. 787-790.

192. Slominski A.T. Ultraviolet radiation (UVR) activates central neuro-endocrine-immune system. Photodermatol Photoimmunol Photomed. 2015 May; 31(3): 121-123.

193. Straburzyсska-Lupa A., Straburzyсski G. Physiotherapy with clinical features. Wyd. Lekarskie, PZWL, Warshawa; 2008 (in Polish).

194. Tenenbaum-Rakover Y., Grasberger H., Mamanasiri S. Loss-of-Function Mutations in the Thyrotropin Receptor Gene as a Major Determinant of Hyperthyrotropinemia in a Consanguineous Community. // J Clin Endocr Metab. 2009; 94(5):1706-1712.

195. Testa A., Castaldi P., Fanti V. Prevalence of HCV antibodies in autoimmune thyroid disease. //. Eur Rev Med Pharmacol Sci. - 2006. - Vol. 10. - P. 183-186.

196. Tomer Y., Davies T.F. Infection, thyroid disease and autoimmunity // Endocrine Rev. - 1993. - Vol. 14. - P. 107-120.

197. Tomer Y. Genetic Susceptibility to Autoimmune Thyroid Disease: Past, Present, and Future. //. Thyroid. - 2010. - Vol. 20. - P. 715-725.

198. Tsunekawa K., Yanagawa Y., Aoki T. Frequency and Clinical Implication of the R450H Mutation in the Thyrotropin Receptor Gene in the Japanese Population Detected by Smart Amplification Process 2. // BioMed Research International. 2014; 2014:1-7.

199. Vaidya B., Chakera A.J., Pearce S.H. Treatment for primary hypothyroidism: Current approaches and future possibilities. // Drug Des Devel Ther. 2011:1.

200. Vanderpump M. P. The epidemiology of thyroid disease.//British Medical Bulleten. - 2011. - Vol. 99. - P. 39 -51.

201. Volpe R. Autoimmune Disease of the Endocrine System. New York, 1990. P. 150-154.

202. Volpe R. Autoimmune diseases of the endocrine system. //. CRC, Boca Raton. . 1990. - P. 1-364.

203. Volpe R. Autoimmunity causing thyroid dysfunction. //. Endocr. Metab. Clin. North. Amer. 1991. Vol. 20. P. 565.587.

204. Weetman A. P. The immunopathogenesis of chronic autoimmune thyroiditis one century after hashimoto. //. Eur Thyroid J. - 2013. - Vol. 1. - P. 243-50.

205. Wiersinga W.M., Duntas L., Fadeyev V. ETA guidelines: The use of l-t4 + l-t3 in the treatment of hypothyroidism. //. Eur Thyroid J. 2012; 1(2):55-71.

206. Whitacre C.C., Sex differences in autoimmune in autoimmune disease. 2001. Nat. Immunol. 2, 777-780.

207. Yang J., Qin Q., Yan N. CD40 C/T(-1) and CTLA-4 A/G(49) SNPs are associated with autoimmune thyroid diseases in the Chinese population // Endocrine. - 2012. - Vol. 41. - P. 111-115.

Размещено на Allbest.ru